Anti-bacterial micro suede integrates silver-ion (Ag+) additives directly into a polyether polyurethane sea-island matrix. This volumetric doping achieves a ≥ 99.9% bacteriostatic reduction rate (ISO 20743). For medical and orthopedic footwear, it permanently prevents microbial maceration and odor accumulation without relying on temporary topical biocides.
Volumetric Doping vs. Topical Biocides
Topical antibacterial sprays applied to standard knitted PU linings fail rapidly in clinical applications. Mechanical friction and exposure to human sweat (lactic acid) strip the surface coating, typically reducing antimicrobial efficacy to < 40% after 10,000 flexing cycles.
To engineer a permanent Anti-bacterial shoe lining, the active agents must be structural. In our production lines, inorganic Ag+ particles are compounded into the DMF-free water-borne polyurethane slurry prior to the wet coagulation phase. The silver ions are locked inside the microscopic voids of the 3D electrospun polyethylene terephthalate (PET) network. When exposed to pathogens like Staphylococcus aureus, the Ag+ ions pierce the bacterial cell membranes, blocking respiration and inhibiting reproduction.
Procurement & QA Notice: Validating microbiological performance for a new clinical footwear line? Request a physical sample roll and our certified laboratory Technical Data Sheet (TDS).
Request Physical Swatches & Lab TDS Report
Quantitative Data: ISO Infection Control Benchmarks
Subjective claims of "odor control" are invalid for Class I medical devices and orthopedic orthotics. Material QA mandates strict adherence to biological evaluation protocols. The matrix below details the tested pathogen resistance of our formulated micro suede.
| Physical Property / Metric | Standard PU Lining | Ag+ Doped Micro Suede | Testing Protocol |
| Antibacterial Efficacy | < 40% Reduction | ≥ 99.9% Reduction | ISO 20743 / JIS L 1902 |
| Fungal (Mildew) Resistance | Grade 3 - 4 (Heavy Growth) | Grade 0 (No Growth) | AATCC 30 / ASTM G21 |
| Skin Sensitization | Variable Risk | Negative (Zero Irritation) | ISO 10993-10 |
| In Vitro Cytotoxicity | Toxic (Solvent Residue) | Non-Cytotoxic (Pass) | ISO 10993-5 |
| Water Vapor Permeability | < 1.0 mg/(cm²·h) | ≥ 2.5 mg/(cm²·h) | EN ISO 20344 |
Compliance Data for Diabetic and Pediatric Footwear
Moisture accumulation in diabetic footwear directly accelerates bacterial maceration and tissue necrosis. The alkali-reduced sea-island architecture of this Medical grade faux suede establishes a high-density microporous network. This yields a Water Vapor Permeability (WVP) of ≥ 2.5 mg/(cm²·h), actively transmitting moisture away from the footbed to physically eliminate the damp environments required for fungal spore germination.
Furthermore, medical procurement requires verifiable chemical safety. Utilizing 100% water-borne PU systems ensures Volatile Organic Compound (VOC) emissions remain ≤ 10 mg/kg. The substrate is entirely free of heavy metals and SVHCs (Substances of Very High Concern), ensuring full EU REACH compliance for direct, sustained dermal contact.
Frequently Asked Questions (FAQ)
Q: How is the antibacterial agent applied to the microfiber leather?
A: We do not use surface sprays. Silver-ion (Ag+) compounds are mixed directly into the liquid polyurethane resin before the wet coagulation process. This locks the active antibacterial agents into the core matrix of the material.
Q: Does the anti-mildew performance degrade after washing or friction?
A: No. Because the Ag+ particles are volumetrically integrated into the 3D sea-island PET network, the anti-mildew resistance (AATCC 30, Grade 0) remains active throughout the mechanical lifespan of the shoe lining.
Q: Is this synthetic leather safe for direct skin contact in medical shoes?
A: Yes. The material passes ISO 10993-10 (Skin Sensitization) and ISO 10993-5 (In Vitro Cytotoxicity). It is manufactured using DMF-free water-borne polyurethane, ensuring it is biochemically safe for patients with compromised dermal integrity.
